ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

Cancer Letter Goes On Vacation

August 16, 1985

Two New Communications Contracts Approved

October 18, 1985

List Of NCI Divisions, Addresses And Telephone Numbers

October 13, 1995

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

September 24, 2010

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

In Brief: FDA Seeks Applicants For Oncology Div. Head; Croce Wins Pasarow Award; CRI Honors Five

August 18, 1995